SECH Albioma

Albioma : Albioma wins 12 MWp in solar projects in France

Albioma : Albioma wins 12 MWp in solar projects in France

Press Release

Paris La Défense, 23 December 2020

Albioma wins 12 MWp in solar projects in France

Albioma has won 12.1 MWp of aggregate capacity in government tenders for the construction and operation of solar power generation facilities, one in non-interconnected zones (ZNI), and the second in mainland France (Innovation, Period 3).

Seventeen projects making for total capacity of 7.6 MWp (rooftop, including storage) were designated winners of the August 2020 call for tenders for ZNIs. These projects are located in Reunion Island, Martinique and Guadeloupe.

One 4.5 MWp project (ground-based, without storage), in Aude, was awarded in Period 3 of the Innovation call for tenders in June 2020.

Construction on these facilities is scheduled to begin in 2021.

Next on the agenda: annual results for the 2020 financial year, on 4 March 2021 (before trading).

About AlbiomaContacts
An independent renewable energy producer, Albioma is engaged in the energy transition through biomass and photovoltaics.



The Group operates in French Overseas Departments, mainland France, Mauritius and Brazil. It has developed a unique partnership with the sugar industry over the past 25 years, to produce renewable energy from bagasse, a fibrous residue from sugar cane.



Albioma is also the leading generator of photovoltaic power in the French Overseas, where it builds and operates innovative projects with integrated storage capabilities. Albioma has recently stepped up its positioning in mainland France.
Investors

Julien Gauthier

+33 (0)1 47 76 67 00



Media

Charlotte Neuvy

+33 (0)1 47 76 66 65

 



 



                            
 
Albioma shares are listed on NYSE EURONEXT PARIS (compartment B) and eligible for the PEA equity savings plans as well as for deferred settlement service (SRD) (ISIN FR0000060402 – ticker symbol ABIO).



The Group is also included in the Gaïa Index, the benchmark for socially-responsible mid-caps.




 

Attachment



EN
23/12/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Albioma

 PRESS RELEASE

Albioma : Press release relating to the squeeze-out procedure for the ...

Albioma : Press release relating to the squeeze-out procedure for the shares and warrants of Albioma PRESS RELEASE DATED SEPTEMBER 29, 2022 RELATING TO THE SQUEEZE-OUT PROCEDURE FOR THE SHARES AND WARRANTS OF ALBIOMA FOLLOWING THE PUBLIC TENDER OFFER INITIATED BY KYOTO BIDCO SAS AMOUNT OF INDEMNIFICATION: 50 euros per Albioma share (ex-dividend) 29,10 euros per Albioma Warrant This press release was prepared and distributed by Kyoto BidCo SAS in accordance with the provisions of Article 237-3 III of the General Regulation of the French Autorité des Marchés Fi...

 PRESS RELEASE

ALBIOMA : Communiqué relatif à la mise en œuvre du retrait obligatoire...

ALBIOMA : Communiqué relatif à la mise en œuvre du retrait obligatoire visant les actions et les BSAAR de la société Albioma Ce communiqué ne constitue pas une offre d’acquisition de titres. COMMUNIQUÉ DE PRESSE DU 29 SEPTEMBRE 2022RELATIF À LA MISE EN OEUVRE DU RETRAIT OBLIGATOIRE VISANT LES ACTIONS ET LES BSAAR DE LA SOCIÉTÉ ALBIOMACONSÉCUTIVEMENT À L’OFFRE PUBLIQUE D’ACHATINITIÉE PARKYOTO BIDCO SAS MONTANT DE L’INDEMNISATION : 50 euros par action Albioma (dividende détaché) 29,10 euros par bon de souscription et/ou d’acquisition d’actions remboursables Albioma Le présent communiqué...

Gaetan Calabro ... (+5)
  • Gaetan Calabro
  • Jeremy Sallee
  • Maxence Dhoury
  • Mohamed Kaabouni
  • Nicolas Royot

La Matinale - 2022-09-15

LA VALEUR DU JOUR : PRODWAYS : Des résultats semestriels exceptionnels / Contact – Acheter (1), obj. 4.00€ Cours: 3.28€ au 14/09/22 ALBIOMA : Vers un retrait de cote Cours: 47.1€ au 14/09/22 CARMAT : Confiant sur la reprise – Acheter (1), obj. 29.0€ Cours: 12.8€ au 14/09/22 ESKER : Un discours (trop?) prudent – Acheter (1), obj. 189.0€ Cours: 131.7€ au 14/09/22 INNATE PHARMA : Horizon de trésorerie confortable et de nouveaux projets à venir – Acheter (1), obj. 6.20€ Cours: 2.58€ au 14/09/22....

 PRESS RELEASE

Albioma : Success of the friendly Tender Offer initiated by KKR

Albioma : Success of the friendly Tender Offer initiated by KKR PRESS RELEASE Paris La Défense, 15 September 2022 Success of the friendly Tender Offer initiated by KKR KKR now holds 92.19% of Albioma’s capital Albioma and KKR announce the results of the friendly Tender Offer for all Albioma securities (the “Offer”) published by the Autorité des marchés financiers (“AMF”) following the closure of the second offer period on 9 September 2022. Following the closure of the second offer period initiated by KKR, 2.536.724 shares and 223 warrants (BSAAR) were tendered. Fol...

 PRESS RELEASE

ALBIOMA : Succès de l'Offre Publique d'Achat amicale initiée par KKR s...

ALBIOMA : Succès de l'Offre Publique d'Achat amicale initiée par KKR sur Albioma Communiqué de presse Paris La Défense, le 15 septembre 2022 Succès de l'Offre Publique d'Achat amicale initiée par KKR sur Albioma KKR détient désormais 92,19% du capital d’Albioma Albioma et KKR annoncent les résultats de l’Offre Publique d’Achat amicale sur l’ensemble des titres d’Albioma (l’« Offre ») publiés par l'Autorité des marchés financiers (« AMF ») à la suite de la clôture de l'Offre rouverte le 9 septembre 2022. A la suite de la clôture de l’Offre rouverte initiée par KK...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch